pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 48 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 3
bevacizumab
Avastin (bevacizumab)
Melanoma
Vascular endothelial growth factor A, long form
F. Hoffmann-La Roche Ltd
5 catalysts
Phase 3
ranibizumab biosimilar
Cimerli (RANIBIZUMAB-EQRN)
Wet (Neovascular / Exudative) Macular Degeneration
Vascular endothelial growth factor A, long form
Lupin Ltd
5 catalysts
Phase 3
dexamethasone acetate
← prev
page 1 of 2
next →
131
Pain89
Neurology1
Ocular Inflammation
Glucocorticoid receptor
$OCSOculis Holding AG
1 catalysts
Phase 3
(neltependocel + Y-27632)
Vyznova (neltependocel [INN])
Corneal Edema
Aurion Biotech Inc
0 catalysts
Phase 3
(riboflavin + sodium iodide)
(riboflavin [INN] + sodium iodide [USP])
Keratoconus
Epion Therapeutics Inc
0 catalysts
Phase 3
4D-150
Wet (Neovascular / Exudative) Macular Degeneration
$FDMT4D Molecular Therapeutics, Inc.
0 catalysts
Phase 3
ATSN-201
Unspecified Ophthalmological Disorders
Atsena Therapeutics Inc
0 catalysts
Phase 3
AVD-104
Dry (Atrophic) Macular Degeneration
Aviceda Therapeutics Inc
0 catalysts
Phase 3
BRM-421
Keratoconjunctivitis Sicca (Dry Eye)
BRIM Biotechnology Inc
0 catalysts
Phase 3
ENB-106
Diabetic Retinopathy
Ennovabio
0 catalysts
Phase 3
K-161
Keratoconjunctivitis Sicca (Dry Eye)
Kowa Co Ltd
0 catalysts
Phase 3
OCU-410ST
Juvenile Macular Degeneration (Stargardt Disease)
$OCGNOcugen, Inc.
0 catalysts
Phase 3
OPGx-LCA5
Leber Congenital Amaurosis (LCA)
$IRDOpus Genetics, Inc.
0 catalysts
Phase 3
PL-9643
Keratoconjunctivitis Sicca (Dry Eye)
$PTNTPALATIN TECHNOLOGIES INC
0 catalysts
Phase 3
Pollinex Quattro Grass
Pollinex
Allergic Rhino-Conjunctivitis
Allergy Therapeutics Plc
0 catalysts
Phase 3
RTX-015
Retinitis Pigmentosa (Retinitis)
Ray Therapeutics Inc
0 catalysts
Phase 3
atropine
atropine [USP]
Myopia
Ocumension Therapeutics Co Ltd
0 catalysts
Phase 3
baluretgene parvec
Retinitis Pigmentosa (Retinitis)
$OCGNOcugen, Inc.
0 catalysts
Phase 3
bimatoprost grenod
Ocular Hypertension
Kowa Co Ltd
0 catalysts
Phase 3
botaretigene sparoparvovec
Retinitis Pigmentosa (Retinitis)
Johnson & Johnson Innovative Medicine
0 catalysts
Phase 3
brolucizumab
Beovu (brolucizumab)
Proliferative Diabetic Retinopathy (PDR)
Vascular endothelial growth factor A, long form
$NVSNOVARTIS AG
0 catalysts
Phase 3
dazdotuftide
dazdotuftide [INN]
Anterior Uveitis
Tarsier Pharma Ltd
0 catalysts
Phase 3
dexamethasone sodium phosphate
SEMDEXA (dexamethasone sodium phosphate)
Ataxia-Telangiectasia (Louis-Bar Syndrome)
Glucocorticoid receptor
$QNCXQuince Therapeutics, Inc.
0 catalysts
Phase 3
elegrobart
Graves' Ophthalmopathy
Viridian Therapeutics Inc
0 catalysts
Phase 3
emixustat hydrochloride
Juvenile Macular Degeneration (Stargardt Disease)
Retinoid isomerohydrolase
Kubota Vision Inc
0 catalysts
Phase 3
gildeuretinol acetate
Juvenile Macular Degeneration (Stargardt Disease)
Alkeus Pharmaceuticals Inc
0 catalysts
Phase 3
ixoberogene soroparvovec
Wet (Neovascular / Exudative) Macular Degeneration
Adverum Biotechnologies Inc
0 catalysts
Phase 3
laruparetigene zovaparvovec
Retinitis Pigmentosa (Retinitis)
Beacon Therapeutics Ltd
0 catalysts
Phase 3
lenadogene nolparvovec
LUMEVOQ (lenadogene nolparvovec [INN])
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy)
GenSight Biologics SA
0 catalysts
Phase 3
licaminlimab
Keratoconjunctivitis Sicca (Dry Eye)
$OCSOculis Holding AG
0 catalysts